National Peroxide has restated its FY26 financial results following an ERP system error that impacted raw material costs. The company reported Q1 FY27 profit of ₹6.61 crore and recommended a 70% dividend.
National Peroxide Restates FY26 Financials Amidst ERP Error
National Peroxide Ltd has announced the retrospective restatement of its financial results for the fiscal year ended March 31, 2026, and the quarter ended December 31, 2025. The company cited an incorrect accounting configuration in its ERP system related to natural gas invoice processing as the reason for the restatement. This error led to an understatement of raw material costs and consequently an overstatement of profits for the affected periods. The company has confirmed the error has been rectified.
What Just Happened
Restatement of FY26 revenue and profit due to ERP configuration error. Discovery of understated raw material costs and overstated profits. Error corrected with immediate effect.
Why This Matters
Investors need to be aware of the corrected FY26 figures to understand the company's true financial performance. The restatement highlights potential issues with internal controls, although the company has assured correction and received an unmodified auditor's report on the revised data.
The Backstory
The financial restatement covers the year ended March 31, 2026, and the quarter ended December 31, 2025. The issue stemmed from how natural gas invoices were processed in the ERP system, leading to accounting inaccuracies.
What Changes Now
The restated FY26 revenue stands at ₹289.71 crore and Profit After Tax (PAT) at ₹5.82 crore. For the first quarter of FY27 (ended June 30, 2026), National Peroxide reported revenue from operations of ₹96.07 crore and PAT of ₹6.61 crore, a significant increase from ₹0.89 crore in the same quarter last year.
Dividend and Corporate Actions
The Board has recommended a final dividend of 70% (₹7 per equity share) for FY26, subject to shareholder approval at the AGM on September 29, 2026. Book closure for the dividend will be from September 23 to September 29, 2026, with a record date of September 22, 2026. The reappointment of Kalyaniwalla & Mistry LLP as Statutory Auditors for a second five-year term was also approved.
Risks to Watch
Investors should monitor future disclosures regarding internal control mechanisms and the reliability of financial reporting to ensure such errors do not recur.
Peer Comparison
(No peer comparison data available in the filing.)
Context Metrics
| Metric | Quarter Ended June 30, 2026 | Quarter Ended June 30, 2025 |
|---|---|---|
| Revenue from Operations | ₹96.07 crore | ₹66.66 crore |
| Profit After Tax | ₹6.61 crore | ₹0.89 crore |
| EPS (Basic/Diluted) | ₹11.50 | ₹1.55 |
What to Track Next
Future financial filings and disclosures regarding internal control improvements will be key for investors.